Filed in archive
Treatment
by Gloria Gamat on October 20, 2006

In a recommended dose of 100 mg once daily, JANUVIA™ is designed to improve blood sugar (glucose) control in patients with type 2 diabetes when diet and exercise is not enough.
However, JANUVIA™ should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, because it will not give the same effect.
Read more from Merck's press release.
Photo Credit: [NY Times]
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/39879
Mr Wong
Vote for DPP-4 Inhibitor by Merck: JANUVIA™, Approved by the USFDA for Type 2 Diabetes:
|
Rating: 7.67 out of 6 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









